Product logins

Find logins to all Clarivate products below.


Peripheral Vascular Devices | Market Insights | US | 2025

The US PV device market is currently seeing a high volume of innovation, with adoption of new, premium technologies and expanding indication approvals for existing devices supporting the market. Although some procedures will face barriers due to a push for cost-effective PV interventions, favorable reimbursement decisions are supporting uptake of other novel technologies.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in the US from 2019 through 2033.

Related Medtech Insights Reports

Report
Peripheral Vascular Devices – Market Insights – United States
The US PV device market will be primarily driven by product innovation, novel technologies, and adoption of premium solutions. However, barriers such as the push for cost-effective PV interventions…
Report
Peripheral Vascular Devices – Market Insights – Europe
The European PV device market will be mainly driven by the increasing availability of premium-priced products and emerging products which, supported by clinical data, will increase the penetration…
Report
Peripheral Vascular Devices – Market Insights – Latin America (Supplemental)
The Latin American PV device market will see increasing penetration of endovascular techniques and increasing uptake of premium-priced products, such as drug-eluting technologies and IVL, as well…
Report
Peripheral Vascular Devices – Market Insights – Latin America
The Latin American PV device market will see increasing penetration of endovascular techniques and increasing uptake of premium-priced products, such as drug-eluting technologies and IVL, as well…
Report
Peripheral Vascular Devices – Market Insights – Asia Pacific (Supplemental)
The Asia Pacific PV device market will grow modestly over the forecast period, driven by the high prevalence of PAD, expanding PAD-related comorbidities, and rising adoption of premium-priced drug-…